Hirokazu Kurokawa
Overview
Explore the profile of Hirokazu Kurokawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuribayashi M, Odaka H, Takahashi S, Tokairin T, Kurokawa H
Medicine (Baltimore)
. 2023 Jul;
102(30):e34492.
PMID: 37505136
Introduction: Vasculitis does not usually induce glandular tissue lesions. Herein, we present a case of vasculitis with a distribution similar to that of immunoglobulin-G4-related disease (IgG4-RD), including that of the...
2.
Okuda Y, Sato K, Asano M, Kudoh K, Omoto E, Izumiya Y, et al.
Geriatr Gerontol Int
. 2023 Jul;
23(8):622-627.
PMID: 37439068
Aim: Akita Prefecture has the largest proportion of older inhabitants and the highest cancer mortality rate in Japan. Lung cancer is one of the biggest killers, and early detection is...
3.
Tomizawa H, Enomoto K, Kurokawa H, Kawai H, Saito Y, Demura R
Kyobu Geka
. 2018 Sep;
71(9):680-684.
PMID: 30185742
Antineutrophil cytoplasmic antibody (ANCA) negative pulmonary limited-form granulomatous with polyangiitis (GPA) is a rare type of GPA. A 53-year-old female had been followed as the possible pulmonary infarction of bilateral...
4.
Kawai H, Saito Y, Demura R, Odaka H, Takahashi S, Takahashi K, et al.
Thorac Cancer
. 2018 Feb;
9(4):495-497.
PMID: 29418077
The options for lung cancer treatment have increased due to the development of immune checkpoint inhibitors, but there has been no report of inoperable cases whereby the treatment effects rendered...
5.
Sato A, Ishida H, Yagisawa H, Kurokawa H
J Med Ultrason (2001)
. 2016 Jun;
33(4):257.
PMID: 27277986
No abstract available.
6.
Katsuura Y, Ishida H, Komatsuda T, Kurokawa H
J Med Ultrason (2001)
. 2016 Jun;
33(4):253-4.
PMID: 27277984
No abstract available.
7.
Sato A, Ishida H, Yagisawa H, Kurokawa H
J Med Ultrason (2001)
. 2016 Jun;
33(3):187-8.
PMID: 27277859
No abstract available.
8.
Muraoka-Cook R, Kurokawa H, Koh Y, Forbes J, Roebuck L, Barcellos-Hoff M, et al.
Cancer Res
. 2004 Dec;
64(24):9002-11.
PMID: 15604265
To address the role of transforming growth factor (TGF) beta in the progression of established tumors while avoiding the confounding inhibitory effects of TGF-beta on early transformation, we generated doxycycline...
9.
Sasaki T, Miura K, Kurokawa H, Akiyama H, Yagi E
Nihon Naika Gakkai Zasshi
. 2003 Mar;
92(1):146-8.
PMID: 12652716
No abstract available.
10.
Kurokawa H, Arteaga C
Clin Cancer Res
. 2003 Jan;
9(1 Pt 2):511S-5S.
PMID: 12538508
It has been reported that overexpression of the epidermal growth factor receptor (erbB1) or its homologous receptor, HER2 (erbB2), can confer antiestrogen resistance to estrogen receptor (ER)-positive human breast cancer...